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http://dx.doi.org/10.1016/j.hkjot.20Summary Objective: This study was conducted to compare the therapeutic effects of health
qigong (HQG) with conventional pulmonary rehabilitation (PR) exercise among patients with
chronic obstructive pulmonary disease (COPD).
Methods: A total of 132 patients with confirmed diagnosis of COPD but no serious comorbidities
were randomly allocated to the HQG group (nZ 51), PR group (nZ 32), or medical treatment
group (n Z 35). The HQG group received 1 week of HQG training under the supervision of
professional coaches, and were then encouraged to participate in a peer-led weekly practice
group thrice a week, lasting 1 hour each time, for 6 months. The conventional PR group
received the same amount of professional coaching on breathing and aerobic exercises, and
peer-led walking or ball game groups. The medical treatment group only received health
education on self-exercise. Baseline data were taken before randomization, and outcomes
were ascertained at the 6-month follow-up by blinded assessors.
Results: Overall, 118 patients with complete data were recruited into the final analysis. Irre-
spective of disease stages, both HQG and PR groups showed improving trends across 6-minute
walk test and quality of life scores, while the medical treatment group demonstrated either no
improvements or some deteriorations. When comparing HQG with PR, HQG appeared to have
better effects on decreasing the frequency of exacerbation for patients with GOLD (Global
Initiative for Chronic Obstructive Lung Disease) stage I and maintaining a stable tumor necrosis
factor-alpha level for patients of GOLD stage II.al Therapy Department, Kowloon Hospital (Rehabilitation Building), 147A Argyle Street, Kowloon,
.H.-P. Ng).
vier (Singapore) Pte. Ltd. All rights reserved.
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Therapeutic effects of qigong 39Conclusion: This study solidifies the concept that both HQG and PR produce positive effects on
subjective symptoms and functions among COPD patients, and also provided evidence that
HQG can induce additional effects compared to conventional PR.
Copyright ª 2012, Elsevier (Singapore) Pte. Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary diseases (COPDs) exert
a great impact on the quality of life (QoL) of patients and
a great burden on the health care system. As the etiology is
related to smoking and biomass fuel use, COPD would be
a major concern in China, where both smoking and the rate
of biomass fuel use are high. In China, the prevalence of
COPD was estimated to be between 5% and 13% in different
provinces/cities, and COPD ranked as the third and fourth
leading cause of death in rural and urban areas, respec-
tively, in 2008. In addition, COPD accounted for 1.6% of all
hospital admissions in China in that same year (Fang, Wang,
& Bai, 2011). Moreover, there is an increasing concern
regarding the systemic components of COPDdi.e., a low-
level increase in inflammatory biomarkers (e.g., TNF-
alpha, interleukin 6, interleukin 8, C-reactive protein),
which may relate to the pathophysiology, morbidity, and
mortality of the disease (Agust et al., 2003; Larsson, 2007).
Pulmonary rehabilitation (PR) with an exercise component
is gaining supporting evidence in terms of its beneficial
effectsdcontrol of symptoms, improvement of exercise
capacity, and improvement of QoL among patients suffering
from COPDdand is recommended to be a major component
in the management of the diseases (Global Initiative for
Chronic Obstructive Lung Disease (GOLD), 2011).
However, there are still controversial issues about the
application of exercise in PR that need to be further studied
in order to obtain the maximum benefit of this treatment
modality. Some issues, for example, include “long term
compliance to home based exercise” (Donesky-Cuenco,
Janson, Neuhaus, Neilands, & Carrieri-Kohlman, 2007),
the potential aggravated inflammatory responses to high
intensity exercise among cachexic COPD patients, which
may induce further muscle wasting (Van Helvoort et al.,
2006). These prompt the need to revisit the conventional
“overload” principle of exercise prescription for COPD
patients, especially when the patients are already at an
advanced stage of the diseases (Puhan, Schu¨nemann, Frey,
Scharplatz, & Bachmann, 2005). Some argue that “low-
intensity and self-paced exercise but on a regular base” can
also produce positive health effects comparable to “high-
intensity exercise” (Varga, Porszaszc, Bodab, Casaburic, &
Somfaya, 2007). On the other hand, there have been
randomized controlled trials reporting empirical evidence
of health qigong’s (HQG) effect in improving exercise
capacity and QoL scores among COPD patients (Chan, Lee,
Suen, & Tam, 2010; Ng, Tsang, Jones, So, & Mok, 2011).
HQG is a Traditional Chinese Medicine (TCM)-based exercise
requiring the regulation of “mind, breathe & posture” in
practice and is a “low-intensity” exercise in nature. The
metabolic equivalents for performing movements of HQG is
estimated to range from 1.5 to 2.6 (Chao, Chen, Lan, & Lai,2002), and the mean of the induced maximum heart rates
ranges from 43% to 49% of predicted maximum heart rates
(Lan, Chou, Chen, Lai, & Wong, 2004). Obviously, its ther-
apeutic effect cannot be explained by the overload prin-
ciple. Thus, we believe that there should be a different
mechanism explaining how HCG works for COPD patients,
and one plausible mechanism is through “anti-inflamma-
tion” as there is a related report in another chronic disease
group with similar systemic inflammation i.e., cancer (Oh
et al., 2010). According to TCM, COPDs are grouped under
the disease category of “cough, breathlessness and lung
inflation” and involve not just the lung but also two other
TMC organs: spleen and kidney. In TCM, HQG is usually
prescribed for COPD patients recovering from exacerbation
with the goal of nourishing all three TCM organs. These TCM
principles align with the modern-day concept that COPD is
not just a pulmonary disease and should be treated in
a holistic way. Thus, this study intends to compare the
therapeutic effects of HQG (the Lung Routines) with
conventional PR program as well as with purely medical
advice with no rehabilitation at all, among COPD patients
with mild to moderate stages of the disease after recovery
from exacerbation and to explore whether HQG can also
produce an anti-inflammatory effect and have an impact on
related biomarkers. The exploration of the therapeutic
mechanism behind this TCM-based rehabilitation modality,
which has not been studied much for the time being, would
have a significant impact on how health care workers in
Western societies view this TCM-based exercise.Methods
Study design
This study features a single-blind, randomized controlled
trial design. Patients with COPD who met the inclusion
criteria (i.e., severity level at GOLD stages I and II, with no
serious comorbidities e.g., pulmonary tuberculosis,
emphysema, congestive heart failure), were randomly
allocated to group IdHQG group (H), group IIdconven-
tional PR group (P), or group IIIdonly medical treatment
group (C). The sample size was estimated based on previous
related studies (Xu, 2000) and set as at least 40 for each
group. With the intention of setting a slightly higher
number for the HQG group (60 HQG vs. 40 PR vs. 40 control)
for a closer investigation of its clinical utilities, the
participant allocation list was drawn based on the random
order of the block “H-H-H-P-P-C-C” for 20 times until a list
of 140 individuals in a specific order was obtained (e.g., the
first randomly drawn “H-P-C-H-P-C-H,” the second
randomly drawn “C-C-P-P-H-H-H”). Baseline data were
taken before randomization, and outcomes were
40 X.-D. Liu et al.ascertained at the 6-month follow-up (FU). All outcome
assessors were blinded to each participant’s allocated
group as well as the objectives of the study to minimize
bias. For immune cell factors, blood sample was obtained
from the median cubital vein by physicians who were also
blinded to each participant’s allocated group. Ethical
approval was sought from all involved settings: the
Shanghai University of Traditional Chinese Medicine and the
Jiangsu Province Hospitals.
Participants
A total of 140 patients with confirmed diagnosis of COPD
were approached and then assessed for severity level [i.e.,
GOLD stages I and II according to their forced expiratory
volume in the 1st second (FEV1) values] and any serious
comorbidities against the inclusion criteria. The patients
were recruited from settings under the care of respiratory
specialists of Jiangsu Province Hospitals from October 2008
to October 2010.
Intervention protocol
Health qigong group
The HQG group received 1 week of HQG training under the
supervision of professional HQG coaches, and then were
encouraged to participate in a peer-led weekly practiceFigure 1 Selected routines from the four standardized health q
from the Chinese Health Qigong Association.group thrice a week, lasting 1 hour each time, for 6
months. The adopted HQG protocol was developed by
Professor Hong-Zhu Jin and his team at Jiangsu Province
Hospitals, and the development was guided by the
following two principles. First, it should be based on
routines selected from the four national standardized
HQG protocols, “Tendon Changing Classic or Yijinjing (易
筋經),” “Frolics of Five Animals or Wuqinxi (五禽戲),”
“The Art of Expiration in Producing Six Different Sounds or
Liuzijue (六字訣),” and “Eight Excellent Movements or
Baduanjin (八段錦),” which have been extensively
studied in mainland China under the national policy of
“revisiting this Chinese heritage from a scientific
view” (Health Qigong Administrative Center of the
General Administration of Sport of China國家體育總局健
身氣功管理中心, 2007). Second, the selected routines
should have been studied for their effect to foster lung
health according to TCM principles (Chen et al., 2008;
Feng, Pan, Wen, Chen, & Jiao, 2009; Zhang, Liu, Jia, &
Yan, 2006) (Fig. 1).
Conventional pulmonary rehabilitation group
The conventional PR group also received a similar amount
of professional input on coaching pursed-lip breathing and
aerobic exercises (e.g., walking, cycling on static bicycle).
They were then encouraged to participate in peer-led
weekly walking and ball game activities thrice a week, 1
hour each time, for 6 months.igong integrated for lung health. Reproduced with permission
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The medical treatment group only received health educa-
tion and was advised to continue exercising by themselves
before the 6-month FU.
Outcome measures
Outcome measures included lung function, 6-minute walk
test (6MWT), Zhongshan COPD questionnaire for QoL,
immune cell factors, including tumor necrosis factor-alpha
(TNF-a), interleukin 6 (IL-6), and IL-8, and number of
hospital admissions due to acute exacerbation of COPD
(AECOPD). Baseline data were taken before randomization,
and outcome data were ascertained at 6-month FU by
blinded assessors, including laboratory assistants for lung
function, research assistants for 6MWT and QoL question-
naire, doctors for taking venous blood samples, and clerical
staff for retrieving admission histories of all involved indi-
viduals. Both lung function and the 6MWT were conducted
according to American Thoracic Society guidelines (ATS
Committee on Proficiency Standards for Clinical Pulmonary
Function Laboratories, 2002). For Quality of Life Ques-
tionnaire, the “Zhong Shan COPD questionnaire” was
adopted for measuring the impact of the disease on the QoL
of patients, as it was developed based on the local pop-
ulation with established validity and reliability, and had
a wider clinical application in China (Cai, Li & Fang, 2004).
It has 35 questions, clustered into four factors; 13 questions
for activity of daily living (ADL), 7 questions for social
participation, 8 questions for depression, and 7 questions
for anxiety. Each question would be rated on a 4-pointFigure 2 CONSOscale, 1 to 4, with lower marks indicating better QoL. For
immune cell factors, blood sample was obtained from the
median cubital vein by the medical doctors in the morning
between 7:30 and 8:00 A.M. after an overnight fast. Blood
samples were centrifuged within 2 hours of collection, and
serum was stored at e20C until assayed. The serum levels
of TNF-a were performed with a commercially available
ELISA kit, following the instructions provided by the
manufacturer (i.e., Shanghai Nuclear Research Institute).
The serum level of IL-6 and IL-8 was analyzed on an
Immulite 1000 automated analyzer (Siemens Medical
Solutions Diagnostics, formally Euro/DPC Ltd, Gwynedd,
Wales, UK).
Analysis
The analysis was done using the per-protocol approachd
i.e., only patients who completed allocated intervention
and assessment would be included in the analysis. One-way
analysis of variance (ANOVA) was conducted for detecting
differences among the three groups. When there was
a significant statistical difference with p value .05, we
proceeded with post-hoc Bonferroni test for testing
differences between each “2 out of 3 groups” combination.
For all outcome measures, except the immune cell factors,
the end point values were used for estimating differences.
For the immune cell factor variables and the variables on
frequency of acute exacerbation, of which the changes
were estimated to be small compared to their baseline
values, we used the “difference between 6M values and the
baseline values” in the analysis. Initially, we recruited allRT diagram.
42 X.-D. Liu et al.participants for the analysis. To study the impact of COPD
stages on outcomes, the same analysis was redone after
separating the patients into stage I and stage II groups.Results
A total of 132 patients met the inclusion criteria and were
enrolled into the studies. Therewere two patients lost to FU,
and seven patients discontinued training and/or defaulted
the 6M FU assessment. The data of one individual was
excluded due to contamination of the assessment data. The
ultimate number of patients for the analysis was 118: group I
(HQG group), n Z 51; group II (conventional PRP), n Z 32;
and group III (only medical treatment group), nZ 35 (Fig. 2).
Analysis of the baseline characteristics supported the fact
that the randomization procedure produced groups with
comparable characteristics (Table 1). The average age of all
participants was 62 years, and 72e80% of them were male.
Abouthalf of themhad their airflow limitationatGOLD stage I
and half of them at GOLD stage II.Table 1 Demographic Data and Baseline Characteristics of the
HQG
Age (y) 61.
Gender
Male 78.
Female 21.
Smoking history
Never smoked 37.
With smoking history 62.
GOLD stage
Stage I 49.
Stage II 51.
Year of COPD 7.
Lung function
FEV1/FVC (%) 60.
FEV1 predicted (%) 74.
Exercise capacity
6MWT (m) 375.
Quality of life score
ADL 22.
Social participation 13.
Anxiety 15.
Depression 12.
Immune cell factors
TNF-a (ng/mL) 2.
IL-8 (ng/mL) 0.
IL-6 (pg/mL) 128.
Number of acute exacerbation 6 mo before recruitment 1.
6MWTZ 6-minute walk test; AECOPDZ acute exacerbation of COPD;
up; FVC Z forced vital capacity; IL-6 Z interleukin 6; IL-8 Z interle
a Values presented as mean (SD).
y p for one-way ANOVA.
# p for chi-square statistic for categorical variable.In reviewing the trends of FEV1 and forced vital
capacity (FVC) changes in the 6-month FU period, all
individuals from the three groups demonstrated a stable
trend; there were no variations and/or deterioration
among the three groups. For their exercise capacity,
however, only the HQG and PR groups demonstrated
considerable improvements, while the control group
showed just a slight improvement (i.e., not greater than
the commonly endorsed minimal clinical significant value
of 50 m). Post hoc test confirmed that the control group
showed less improvement compared to HQG and PR
groups, and there were no differences in the levels of
improvement between HQG and PR groups. This pattern of
difference among the groups was also identified in the
“Anxiety” and “Depression” subscores of the QoL ques-
tionnaire, but not in the “ADL” parameter. In the ADL
parameter, only the HQG group had a significantly lower
score (which indicates better ADL performance) than
the control group. However, this improvement in the
HQG group did not reach statistical significance when
compared to the PR group. For immune cell factors, thereStudy Sample by Group Allocation.
(n Z 51) PRP (n Z 32) Control (n Z 35) p
82 (7.69)a 61.34 (8.34)a 62.2 (6.34)a .90y
4% 71.9% 80.0% .70#
6% 28.1% 20.0%
3% 43.8% 34.3% .72#
7% 56.3% 65.7%
0% 46.9% 48.6% .98#
0% 53.1% 51.4%
54 (2.73)a 7.75 (2.20)a 7.57 (2.97)a .94y
73 (6.18)a 61.27 (5.86)a 61.43 (6.17)a .86y
43 (12.93)a 75.31 (12.84)a 75.31 (13.79)a .94y
28 (31.12)a 378.91 (31.03)a 381.91 (28.94)a .61y
73 (3.07)a 22.41(3.39)a 22.43 (3.11)a .87y
02 (2.18)a 13.09 (2.61)a 13.57 (2.43)a .55y
41 (2.70)a 14.69 (2.53)a 14.77 (2.66)a .38y
78 (1.90)a 12.19 (1.94)a 12.69 (1.92)a .37y
36 (0.35)a 2.37 (0.34)a 2.40 (0.40)a .89y
52 (0.08)a 0.51 (0.05)a 0.50 (0.08)a .41y
73 (33.77)a 124.59 (34.51)a 129.22 (36.49)a .83y
55 (0.70)a 1.38 (0.55)a 1.43 (0.65)a .46y
FEV1Z forced expiratory volume in the 1st second; FUZ follow-
ukin 8; TNF-a Z tumor necrosis factor-alpha.
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patients in the HQG group when compared to their
counterparts in the control group. For the change in
frequency in AECOPD, there was no difference among the
three groups (Table 2).
After dividing the groups into GOLD stage I and II
according to their level of airflow limitation and redoing
the analysis, a slightly different pattern of difference in
the outcome parameters was noted. Among the GOLD stage
I patients, HQG showed a better protective effect against
AECOPD than the other two groups, and a better
improvement in “depression” when compared to the
control group (Table 3). Among GOLD stage II patients, HQG
produced a better protective effect against systemic
inflammation (i.e., a more stable TNF-alpha level, while
there were increase in TNF-alpha level in both PR and
control groups) and a better improvement in 6MWT and ADL
(Table 4).Table 2 Comparison of Outcomes at 6M FU for All Participants.
Outcome variables HQG PRP
Lung function
FEV1/FVC (%) 6M FU 61.93 (5.94)
a 62.02 (5.75
Baseline 60.73 (6.18)a 61.27 (5.86
FEV1 predicted (%) 6M FU 75.47 (12.43)
a 76.22 (12.4
Baseline 74.43 (12.93)a 75.31 (12.8
Exercise capacity
6 MWT (m) 6M FU 434.53 (28.70)a 435.69 (23.7
Baseline 375.28 (31.12)a 378.91 (31.0
Quality of life score
ADL 6M FU 19.04 (2.95)a 20.38 (3.00
Baseline 22.73 (3.07)a 22.41 (3.39
Social participation 6M FU 12.78 (1.75)a 12.94 (2.11
Baseline 13.02 (2.18)a 13.09 (2.61
Anxiety 6M FU 13.57 (2.62)a 13.47 (2.62
Baseline 15.41 (2.70)a 14.69 (2.53
Depression 6M FU 11.39 (1.92)a 11.41 (1.52
Baseline 12.78 (1.90)a 12.19 (1.94
Immune cell factors
TNF-a (ng/mL) D (6M e
Baseline)
0.08 (0.21)a 0.10 (0.13
IL-8 (ng/mL) D (6M e
Baseline)
0.01 (0.06)a 0.02 (0.03
IL-6 (pg/mL) D (6M e
Baseline)
1.38 (16.64)a 5.41 (12.4
Number of AECOPD D (6M e
Baseline)
e0.31 (0.53)a e0.34 (0.55
DZ change; 6MWTZ 6-minute walk test; AECOPDZ acute exacerba
FU Z follow-up; FVC Z forced vital capacity; HQG Z health qigon
rehabilitation; TNF-a Z tumor necrosis factor alpha.
*Statistically significant difference with p < .05 in one-way ANOVA co
^Statistically significant difference with p < .05 in post-hoc Bonferron
a Values presented as mean (SD).Discussion
The findings of this study are similar to those of other
related studies. Exercise, regardless of its format and the
ways used to support exercising behaviors (e.g., the peer-
led group, a venue for exercising), is important in the
management of COPD. Both HQG and conventional PR
offered benefits in improving exercise capacity and
relieving negative psychological states (i.e., anxiety and
depression) as compared with no active exercise group.
This study demonstrated that even a low-cost setup with
support from peers was good enough to produce some
improvement, and even patients with a mild-to-moderate
level of COPD can also benefit from the training. We
postulated that in case there would be more professional
input in the infrastructure to refine the patients’ exer-
cising techniques, meet the patients’ individual needs,
and give feedback and/or reinforcement, greaterControl ANOVA p Bonferroni p
Control
versus
PRP
Control
versus
HQG
PRP
versus
HQG
)a 61.85 (5.90)a .99 > .99 > .99 > .99
)a 61.43 (6.17)a
7)a 75.34 (12.89)a .95 > .99 > .99 > .99
4)a 75.31 (13.79)a
8) 407.14 (22.75)a < .001* < .001^ < .001^ > .99
3)a 381.91 (28.94)a
)a 21.83 (2.89)a < .001* .14 < .001^ .14
)a 22.43 (3.11)a
)a 13.26 (2.34)a .57 > .99 .88 > .99
)a 13.57 (2.43)a
)a 15.03 (2.81)a .02* .05^ .04^ > .99
)a 14.77 (2.66)a
)a 12.71 (1.99)a < .001* .01^ < .001^ > .99
)a 12.69 (1.92)a
)a 0.19 (0.24) .02* > .99 .04^ .13
)a 0.02 (0.03) .39 .67 .69 > .99
5)a 5.31 (20.24) .53 > .99 .91 > .99
)a e0.47 (0.50) .34 > .99 .53 .85
tion of COPD; FEV1Z forced expiratory volume in the 1st second;
g; IL-6 Z interleukin 6; IL-8 Z interleukin 8; PRP Z pulmonary
mparison among the three groups.
i paired-group comparison.
Table 3 Comparison of Outcomes for GOLD Stage I.
Outcome variables ANOVA p Bonferroni p
Control versus PRP Control versus HQG PRP versus HQG
Lung function
FEV1/FVC (%) .69 > .99 > .99 > .99
FEV1 predicted (%) .48 > .99 > .99 .69
Exercise capacity
6 MWT (m) < .001* < .001^ < .001^ > .99
Quality of life score
ADL .10 .53 .10 > .99
Social participation .72 > .99 > .99 > .99
Anxiety < .001* .03^ < .001^ > .99
Depression .04* .68 .03^ .68
Immune cell factors
D TNF (ng/mL) .27 .79 .34 > .99
D IL-8 (ng/mL) .53 > .99 .90 > .99
D IL-6 (pg/mL) .63 > .99 > .99 > .99
D AECOPD between the observation periods .01* > .99 .01^ .03^
DZ change; 6MWTZ 6-minute walk test; AECOPDZ acute exacerbation of COPD; FEV1Z forced expiratory volume in the 1st second;
FVCZ forced vital capacity; GOLDZ Global Initiative for Chronic Obstructive Lung Disease; HQGZ health qigong; IL-6Z interleukin 6;
IL-8 Z interleukin 8; PRP Z pulmonary rehabilitation; TNF-a Z tumor necrosis factor alpha.
*Statistically significant difference with p < .05 in one-way ANOVA comparison among the three groups.
^Statistically significant difference with p < .05 in post-hoc Bonferroni paired-group comparison.
44 X.-D. Liu et al.improvements might be realized. In relation to exercise
modality, HQG appeared to have a better effect in
enhancing ADL function and offering better protection
against systemic inflammation, as there was a significant
difference in comparison with the control group while theTable 4 Comparison of Outcomes for GOLD Stage II.
Outcome variables ANOVA p
Co
Lung function
FEV1/FVC (%) .95 >
FEV1 predicted (%) .86 >
Exercise capacity
6 MWT (m) .04*
Quality of life score
ADL < .001*
Social participation .12
Anxiety .37
Depression .01*
Immune cell factors
D TNF (ng/mL) .01* >
D IL-8 (ng/mL) .73 >
D IL-6 (pg/mL) .84 >
D AECOPD between the observation periods .75 >
DZ change; 6MWTZ 6-minute walk test; AECOPDZ acute exacerba
FVCZ forced vital capacity; GOLDZ Global Initiative for Chronic Obs
IL-8 Z interleukin 8; PRP Z pulmonary rehabilitation; TNF-a Z tum
*Statistically significant difference with p < .05 in one-way ANOVA co
^Statistically significant difference with p < .05 in post-hoc BonferronPR group did not produce this level of improvement. When
we analyzed the COPD patients in separate groups
according to their levels of airflow limitation, we found
that there was a different pattern of changes, which
implied that the severity in airflow limitation did shapeBonferroni p
ntrol versus PRP Control versus HQG PRP versus HQG
.99 > .99 > .99
.99 > .99 > .99
.15 .04^ > .99
.36 < .001^ .10
.20 .24 > .99
.48 > .99 > .99
.01^ .07 .62
.99 .07 .02^
.99 > .99 > .99
.99 > .99 > .99
.99 > .99 > .99
tion of COPD; FEV1Z forced expiratory volume in the 1st second;
tructive Lung Disease; HQGZ health qigong; IL-6Z interleukin 6;
or necrosis factor alpha.
mparison among the three groups.
i paired-group comparison.
Therapeutic effects of qigong 45different responses to the two exercise modalities: HQG
versus aerobic and breathing exercise of PR. HQG may
offer better protection against AECOPD among GOLD stage
I COPD patients, and better protection against systemic
inflammation and improvement in exercise capacity and
ADL among GOLD stage II COPD patients. There had been
discussions on high levels of circulating inflammatory
cytokines (TNF-alpha) appearing to cause muscle
dysfunction in COPD patients through an imbalance
between muscle protein synthesis and degradation, and
long-term low-intensity exercise may be more appropriate
and beneficial to those COPD patients with muscle wasting
in terms of its potential anti-inflammatory effect
(Garroda, Ansleyb, Canavana, & Jewell, 2007; van der
Vlist & Janssen, 2010). This study produced some
evidence supporting this view, as HQGdbeing a more
relaxing and gentle form of exercisedappeared to
produce a protective effect against inflammation, and
a better improvement exercise capacity and ADL among
patients with advanced-stage COPD. A recent systematic
review also postulated that the therapeutic mechanism
behind HQG may pertain to stress reduction via nervous,
endocrine, and immune systems (Ng & Tsang, 2009). Slow
and deep breathing pattern can correct the sym-
pathovagal imbalance (Raupach et al., 2008) and produce
a calming effect (Chan, Cheung, Sze, Leung, & Shi, 2011),
while stress reduction can, in turn, have a positive effect
on anti-inflammation (Einvik et al., 2011). On the other
hand, another way to achieve anti-inflammatory effect
may be obtained through activities involving large muscle
groups when performing many transient semisquatting
postures within the clients’ tolerance during the practice
of HQG, which act as a source of producing IL-6 for
mediating the anti-inflammatory effect (Mathur &
Pedersen, 2008). In our data, it also appears that there
are lesser changes in IL-6 levels among patients from the
HQG group compared with patients from the other two
groups. Moreover, from the movement analysis, HQG may
also have the following potential therapeutic effect on
COPD: (a) slow and deep breathing may relieve dynamic
hyperinflation, which is closely related to dyspnea, as
identified in most COPD patients during exercise
(Macklem, 2010); (b) inhalation coordinated with
stretching out movements of the upper limbs may create
more chest expansion, and hence, a potential higher
negative intrathoracic pressure to facilitate the air to
move in; and (c) the sideways bending and twisting
movements of the trunk may loosen up tight structures
and hence decrease the workload in respiration.
This study has several limitations. First, only the per-
protocol analysis (which only involved patients who
completed the protocol and assessment) rather than
intention-to-treat analysis was conducted, because we
failed to trace the outcome of those who defaulted either
during training and/or FU assessment. However, the rela-
tively low number of patients lost to FU and treatment
discontinuation might have helped in improving the validity
of our current analysis. Second, dyspnea, which was
a major complaint among COPD patients, was not directly
assessed in this study. In any future study, we should
consider choosing a QoL tool that includes this aspect e.g.,
the Chronic Respiratory Questionnaire (Chan et al., 2006).Conclusion
Regardless of the format used, HQG or conventional PR,
rehabilitation exercise produces positive effects on health,
subjective symptoms, and functions among patients
suffering from COPD. This study solidifies the concept that
rehabilitation is essential in the management of COPD.
Moreover, this study contributes further evidence to support
HQGas an alternative formof exercise for COPDpatients that
should be considered to suit individual factors (e.g., severity
of airflow limitation, cost, interest, perceived benefits),
especiallywhen the ultimatemanagement goal is to promote
long-termexercise habits. This study also highlights areas for
future studiesde.g., anti-inflammatory effect of HQG
among muscle-wasted patients with COPD, potential effect
of HQG to relieve dyspnea.References
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